Glen Eagle Advisors’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-75
Closed -$6.04K 1075
2021
Q2
$6.04K Hold
75
﹤0.01% 788
2021
Q1
$5.1K Sell
75
-10
-12% -$786 ﹤0.01% 766
2020
Q4
$5.92K Hold
85
﹤0.01% 713
2020
Q3
$4.37K Hold
85
﹤0.01% 709
2020
Q2
$4.99K Buy
85
+10
+13% +$553 ﹤0.01% 666
2020
Q1
$3.79K Sell
75
-50
-40% -$3.32K ﹤0.01% 659
2019
Q4
$9.26K Hold
125
﹤0.01% 604
2019
Q3
$7.14K Hold
125
﹤0.01% 565
2019
Q2
$8.18K Buy
125
+75
+150% +$5.22K 0.01% 536
2019
Q1
$3.7K Hold
50
﹤0.01% 609
2018
Q4
$2.98K Hold
50
﹤0.01% 598
2018
Q3
$4.72K Sell
50
-50
-50% -$4.31K ﹤0.01% 567
2018
Q2
$7.51K Hold
100
0.01% 498
2018
Q1
$6.05K Buy
100
+20
+25% +$1.08K 0.01% 502
2017
Q4
$3.73K Sell
80
-60
-43% -$2.97K ﹤0.01% 540
2017
Q3
$7.08K Hold
140
0.01% 477
2017
Q2
$6.98K Buy
140
+30
+27% +$1.4K 0.01% 444
2017
Q1
$4.67K Buy
+110
New +$4.87K ﹤0.01% 465

Other funds holding HQY

Glen Eagle Advisors's HQY Position: Q3 2021 in Review

Glen Eagle Advisors sold out of HealthEquity (HQY) in Q3 2021, closing a stake of 75 shares — an estimated $6.04K sold.

Glen Eagle Advisors first reported a position in HQY in Q1 2017 and held it in 18 quarters. The position peaked at $9.26K in Q4 2019. 286 funds tracked by Wall St. Rank hold HQY as of Q3 2021.

  • Glen Eagle Advisors reported no remaining HealthEquity position as of Q3 2021 after selling out during the quarter.
  • Glen Eagle Advisors sold 75 HealthEquity shares in Q3 2021, an estimated $6.04K.
  • Glen Eagle Advisors first reported a position in HealthEquity in Q1 2017 and held it in 18 quarters.
  • Glen Eagle Advisors's HealthEquity position peaked at $9.26K in Q4 2019.
  • 286 funds tracked by Wall St. Rank held HealthEquity as of Q3 2021.

Based on Glen Eagle Advisors's 13F filing for Q3 2021, filed 13 Aug 2024.